[3] However, despite the growth in adoption, Ketamine remains a controlled substance and ketamine behavioral health remains an industry with material regulatory risks. We have set forth certain key considerations for various stakeholders involved with ketamine behavioral health. [5]Notably, ketamine infusions or prescriptions for behavioral health matters are generally not reimbursable by Medicare or other federal health care programs. Because state laws vary widely with respect to CPOM restrictions, it is important to review state laws carefully and structure for specific requirements. We recommend a careful review of a ketamine behavioral health platform’s model against the backdrop of federal and state laws in order to develop optimal and compliant legal structures.

Source: Forbes October 28, 2021 21:41 UTC